RemeGen board approves A-share repurchase for employee incentives

RemeGen Co., Ltd. announced that its board of directors approved a resolution on December 15, 2025, to repurchase a portion of its A-shares. The primary purpose is to implement an employee equity incentive scheme in the future. The company plans to use its own funds and/or self-raised funds for this initiative, with any unutilized repurchased shares to be canceled within three years of the implementation results and share changes.

The total value of the A-share repurchase is set to be between RMB20 million and RMB40 million. The maximum repurchase price per share will not exceed RMB95, which is no more than 150% of the average stock trading price over the 30 days preceding the board's approval. Based on the maximum price, RemeGen expects to repurchase between 210,500 and 421,100 A-shares.

The repurchase period will not exceed 12 months from the board approval date. As of December 15, 2025, controlling shareholders, actual controllers, and major shareholders have no immediate plans to reduce their A-share holdings. The company believes this repurchase will align shareholder and employee interests and enhance investor confidence.